To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Monomil® XL) 60mg modified release tablet, from 26 March 2024 to 3 May 2024.

This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of shingles and skin infections under NHS Pharmacy First Scotland.

This Circular advises NHS Boards and healthcare professionals that print copies of the British National Formulary (BNF) and BNF for Children (BNFC) will no longer be provided

PCA(P)(2023)46 - Pharmaceutical Services Amendments To The Drug Tariff Part 11 Discount Clawback Scale

This Circular provides updated guidance aimed at both community optometry and community pharmacy teams and an updated referral form for the assessment and treatment of minor eye conditions.

This circular advises community pharmacy contractors and Health Boards of a corrective payment in order to deliver contractual requirements for the financial year 2023/24.

This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin

This circular informs NHS Boards and community pharmacy contractors of the intention to continue funding for Community Pharmacist Practitioner Champions in 2023-24.

This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin

This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot®

This Circular advises NHS Boards and community pharmacy contractors of the next Public Health Service (PHS) poster campaign topics which will be distributed to pharmacies.

This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Jext® 300 micrograms/ 0.3mL (1 in 1000) solution for injection auto-injector pen

This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot® (estradiol hemihydrate) 100 microgram patches

This Circular advises community pharmacy contractors that two of the UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic

This circular advises of changes to the Drug Tariff with respect to remuneration arrangements for the dispensing pool month of July.

This circular informs NHS Boards and community pharmacy contractors of the intention to continue funding for Community Pharmacist Practitioner Champions in 2023-24.

This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot® (estradiol hemihydrate) 100 microgram patches

This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Utrogestan®

To advise of a Serious Shortage Protocol (SSP) in place for Jext® 300 micrograms/0.3mL (1 in 1000) solution for injection auto-injector pen, from 21 August 2023 to 15 September 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Estradot® (Estradiol hemihydrate) 100 microgram patches, from 21 August 2023 to 8 September 2023.

This Circular advises community pharmacy contractors that the Serious Shortage Protocol (SSP) for Progynova®

This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Utrogestan® (micronised progesterone) 100mg capsules

Patient Group Directions (PGDs) that are to be added to the NHS Pharmacy First Scotland service for the treatment of seasonal allergic rhinitis (hay fever).

This circular sets out to community pharmacy contractors and NHS Boards the details of the community pharmacy funding arrangement 2023/24

Two of the UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic products due to expire on 21 July 2023 have now been extended

The UK-wide active Serious Shortage Protocol (SSP) for Progynova® (estradiol) TS 100 microgram patches, a hormone replacement therapy (HRT)

This Circular advises of changes to the Scottish Drug Tariff effective from 1 May 2023 in respect of reimbursement of costs borne by community pharmacy contractors when dispensing NHS prescriptions for part 7 medicines.

A new naloxone service to be implemented in community pharmacies later this year, preparation work that will be required and a payment for associated costs.

To advise of a Serious Shortage Protocol (SSP) in place for Utrogestan® (micronised progesterone) 100mg capsules, from 19 May 2023 to 18 August 2023.

This Circular provides an updated Gluten Free Food Prescribable Product List to be used in conjunction with the community pharmacy Gluten Free Food Service (GFFS).